我要投票 民康制药在医疗器械行业中的票数:347
· 外 推 电 报 ·
2025-08-12 04:07:29 星期二

【民康制药是哪个国家的品牌?】

民康制药是什么牌子?「民康制药」是 湖北民康制药有限公司 旗下著名品牌。该品牌发源于湖北省宜昌市,由创始人李美林在2003-12-18期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力民康制药品牌出海!将品牌入驻外推网,定制民康制药品牌推广信息,可以显著提高民康制药产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

湖北民康制药有限公司,位于峡口明珠——湖北省宜昌市,起源于清朝末年川东鄂西久负盛名的“兴盛祥”药材号,已有百年历史。创立至今,湖北民康制药有限公司秉承“百年潜心造好药,民康为您保健康”的宗旨,坚持走专业化的发展道路,以研发为动力、质量为保障、服务为依托,不断发展壮大企业规模,目前已有各类专业技术人员三百余人。技术力量雄厚,设备精湛,工艺专业,拥有一套完整的产品质量监控体系。本公司生产十余种剂型,一百多个批准文号,四百余种品规,因配料严格、工艺精细、质量稳定、疗效确切而畅销全国各地,并远销海外。

湖北民康制药生产的中药浓缩丸、超浓缩丸、合剂,秉承“传统工艺中成药”的制药理念,融合现代专业技术,工艺独特考究,其品质稳居全国前列水平,多个品种获准进入香港、澳门、欧美、日本以及东南亚市场。 

“百年潜心造好药,民康为您保健康”。


英文翻译:Hubei Minkang Pharmaceutical Co., Ltd. is located in Yichang City, Hubei Province, the Pearl of Xiakou. It originated from the famous "xingshengxiang" medicinal material of Eastern Sichuan and Western Hubei in the late Qing Dynasty, and has a history of one hundred years. Since its establishment, Hubei Minkang Pharmaceutical Co., Ltd. has been adhering to the tenet of "one hundred years of devoting to making good medicine, and Minkang will protect your health". It adheres to the development path of specialization, takes research and development as the driving force, quality as the guarantee and service as the support, and constantly develops and expands the enterprise scale. At present, there are more than 300 professional and technical personnel of all kinds. Strong technical force, exquisite equipment, professional technology, with a complete set of product quality monitoring system. The company produces more than ten dosage forms, more than one hundred approval numbers and more than four hundred product specifications, which sell well all over the country due to strict ingredients, fine technology, stable quality and exact curative effect, and are exported overseas. The traditional Chinese medicine concentrated pill, super concentrated pill and mixture produced by Hubei Minkang Pharmaceutical Co., Ltd. adhere to the pharmaceutical concept of "traditional Chinese patent medicine", integrate modern professional technology, and have unique and exquisite technology. Its quality ranks the top level in China, and many varieties are approved to enter Hong Kong, Macao, Europe, America, Japan and Southeast Asia markets. "A hundred years of painstaking efforts to make good medicine, Minkang to protect your health.".

本文链接: https://www.waitui.com/brand/5bfbaff88.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

东风集团股份:1-7月累计汽车销量同比下降约8.9%

36氪获悉,东风集团股份发布公告,1-7月累计汽车销量为978462辆,同比下降约8.9%。其中,新能源汽车销量为249571辆,同比增长约35.5%。母公司东风汽车集团有限公司1-7月累计汽车销量为1260406辆,同比下降约10.8%。

8分钟前

奇德新材:实控人拟减持公司不超2%股份

36氪获悉,奇德新材发布公告,公司控股股东、实控人饶德生计划以集中竞价、大宗交易方式,合计减持公司股份不超过167.91万股,即不超过公司扣除回购专户股份后总股本的2%。

8分钟前

美股大型科技股盘前多数上涨,特斯拉涨超2%

36氪获悉,美股大型科技股盘前多数上涨,截至发稿,英特尔、特斯拉涨超2%,亚马逊涨0.39%,Meta涨0.19%,微软涨0.18%,奈飞涨0.11%;苹果跌0.52%,英伟达跌0.4%,谷歌跌0.23%。

8分钟前

热门中概股美股盘前多数上涨,小鹏汽车涨超4%

36氪获悉,热门中概股美股盘前多数上涨,截至发稿,小鹏汽车涨超4%,哔哩哔哩、蔚来涨超2%,拼多多涨0.29%,百度涨0.21%;理想汽车跌超2%,京东跌0.76%,阿里巴巴跌0,02%。

8分钟前

英伟达与AMD同意向美政府上缴15%的收入,外交部回应

8月11日,外交部发言人林剑答记者问。路透社记者提问,据报道,英伟达公司与超威半导体公司已同意向美国政府上缴在华芯片销售收入的15%,以换取对华出口许可证。中方对此有何评论?(英国广播公司亦问及)林剑表示,在美输华芯片问题上,中方已经多次表明了立场。(北京日报)

8分钟前

本页详细列出关于民康制药的品牌信息,含品牌所属公司介绍,民康制药所处行业的品牌地位及优势。
咨询